Lysosomal Storage Disorders in the Newborn
暂无分享,去创建一个
Ellen Sidransky | Donna Krasnewich | D. Krasnewich | E. Sidransky | Mary E LaMarca | M. Lamarca | Orna Staretz-Chacham | Tess C Lang | O. Staretz-Chacham
[1] M. Hod,et al. Isolated fetal ascites caused by Wolman disease , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[2] H. Enders,et al. Restrictive dermopathy: report and review. , 1997, American journal of medical genetics.
[3] N. Ozbek,et al. A Very Unusual Presentation of Niemann-Pick Disease Type B in an Infant: Similar Findings to Congenital Lobar Emphysema , 2005, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[4] M. Verity,et al. Infantile Pompe's disease, lipid storage, and partial carnitine deficiency , 1991, Muscle & nerve.
[5] David J. Loren,et al. Sialidosis Presenting as Severe Nonimmune Fetal Hydrops is Associated with Two Novel Mutations in Lysosomal α-Neuraminidase , 2005, Journal of Perinatology.
[6] H. Sudhof,et al. [Congenital Gaucher's disease in erythroblastosis and vascular sclerosis]. , 1954, Klinische Wochenschrift.
[7] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[8] A. Tylki-Szymańska,et al. Neuraminidase deficiency presenting as a nephrosialidosis: The first case detected in Poland , 1996, Acta paediatrica Japonica : Overseas edition.
[9] T. Daly,et al. Gene therapy for lysosomal storage diseases. , 1998, Expert opinion on investigational drugs.
[10] C. Hollak,et al. Novel therapeutic targets for the treatment of Fabry disease , 2007, Expert opinion on therapeutic targets.
[11] M. Elleder,et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. , 2001, Human molecular genetics.
[12] M. Rybojad,et al. [Extensive Mongolian spot related to Hurler disease]. , 1999, Annales de dermatologie et de venereologie.
[13] M. Elleder,et al. Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. , 2005, Neuropediatrics.
[14] H. Moser,et al. Early manifestations of multiple sulfatase deficiency. , 1984, The Journal of pediatrics.
[15] M. Senat,et al. Second‐trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis , 2006, Prenatal diagnosis.
[16] E. Blair,et al. Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. , 1997, Journal of clinical pathology.
[17] M. Nakayama,et al. A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. , 2001, The Journal of pediatrics.
[18] A. Smits,et al. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[19] J. Clarke,et al. Early infantile variant of Krabbe globoid cell leucodystrophy with lung involvement. , 1981, Archives of disease in childhood.
[20] R. Schiffmann,et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. , 1998, Human gene therapy.
[21] E. Sidransky,et al. PERINATAL LETHAL GAUCHER DISEASE: A DISTINCT PHENOTYPE ALONG THE NEURONOPATHIC CONTINUUM , 2005, Fetal and pediatric pathology.
[22] F. Van hoof,et al. Ocular findings in I-cell disease (mucolipidosis type II). , 1977, American journal of ophthalmology.
[23] K. Zerres,et al. Nonimmune hydrops fetalis with galactosialidosis: consequences for family planning. , 1996, Fetal diagnosis and therapy.
[24] T. Butters. Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders , 2007, Expert opinion on pharmacotherapy.
[25] E. M. Schoonderwaldt,et al. In‐utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[26] W. Mcalister,et al. Neonatal mucolipidosis II (I-cell disease) with dysharmonic epiphyseal ossification and butterfly vertebral body. , 1996, Journal of perinatology : official journal of the California Perinatal Association.
[27] C. Noehammer,et al. Metabolic cardiomyopathies , 2000, International journal of experimental pathology.
[28] D. Roberts,et al. Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. , 1991, Pediatric pathology.
[29] E. Sidransky,et al. Hydrops fetalis: lysosomal storage disorders in extremis. , 1999, Advances in pediatrics.
[30] A. Reuser,et al. Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II. , 2007, Molecular genetics and metabolism.
[31] N. Conradi,et al. Early-infantile galactosialidosis with multiple brain infarctions: morphological, neuropathological and neurochemical findings , 1996, Acta Neuropathologica.
[32] W. Sly,et al. PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase gene. , 2007, Genetic testing.
[33] J. Fletcher. Screening for lysosomal storage disorders—A clinical perspective , 2006, Journal of Inherited Metabolic Disease.
[34] N. S. Warren,et al. Fetal mucolipidosis II (I-cell disease): radiologic and pathologic correlation , 2006, Pediatric Radiology.
[35] J. Kelly,et al. Pharmacologic chaperoning as a strategy to treat Gaucher disease , 2007, The FEBS journal.
[36] R. Barone,et al. Inter‐ and intrafamilial variability in mucolipidosis II (I‐cell disease) , 1995, Clinical genetics.
[37] R. Carmi,et al. Niemann-Pick disease associated with nonimmune hydrops fetalis. , 1990, American journal of obstetrics and gynecology.
[38] M. Sanseverino,et al. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis , 2004, Prenatal diagnosis.
[39] O. Linderkamp,et al. Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. , 1999, American journal of perinatology.
[40] E. Çakir,et al. A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis , 2002, Child's Nervous System.
[41] M. Akçam. Infantile Pompe's disease presenting with pulmonary infections during the newborn period. , 2004, Saudi Medical Journal.
[42] H. Patriquin,et al. Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. , 1977, AJR. American journal of roentgenology.
[43] A. Kher,et al. Mucolipidoses—II: a report of three cases , 1995, Indian journal of pediatrics.
[44] B. Siassi,et al. A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth , 2002, Journal of perinatal medicine.
[45] Wuh-Liang Hwu,et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, The Journal of pediatrics.
[46] R. D. Wilson,et al. Morquio disease presenting as hydrops fetalis and enzyme analysis of chorionic villus tissue in a subsequent pregnancy. , 1987, Pediatric pathology.
[47] A. Beaudet,et al. Variation in the phenotypic expression of β-glucuronidase deficiency , 1975 .
[48] E. Cutz,et al. Congenital ascites as a presenting sign of lysosomal storage disease. , 1984, The Journal of pediatrics.
[49] C. Vaillant,et al. Forme respiratoire néonatale létale de la maladie de Niemann-Pick C2 et diagnostic anténatal par l'étude des mutations du gène HE1/NPC2 , 2005 .
[50] D. Landau,et al. A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred. , 2004, Molecular genetics and metabolism.
[51] E. Zammarchi,et al. β‐galactosidase gene mutations affecting the lysosomal enzyme and the elastin‐binding protein in GM1‐gangliosidosis patients with cardiac involvement , 2000, Human mutation.
[52] M. Verity,et al. Infantile Pompe's disease, lipid storage, and partial carnitine deficiency , 1991, Muscle & nerve.
[53] D. Sherer,et al. Congenital ichthyosis with restrictive dermopathy and gaucher disease: A new syndrome with associated prenatal diagnostic and pathology findings , 1993, Obstetrics and gynecology.
[54] W. Krivit. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases , 2004, Springer Seminars in Immunopathology.
[55] S. Ishii,et al. Active‐site‐specific chaperone therapy for Fabry disease , 2007, The FEBS journal.
[56] Christopher P Austin,et al. Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease , 2007, Proceedings of the National Academy of Sciences.
[57] S. Withers,et al. Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients* , 2004, Journal of Biological Chemistry.
[58] E. Lemyre,et al. Clinical spectrum of infantile free sialic acid storage disease. , 1999, American journal of medical genetics.
[59] J. Callahan,et al. Infantile sialidosis: a phenocopy of type 1 GM1 gangliosidosis distinguished by genetic complementation and urinary oligosaccharides. , 1979, American journal of human genetics.
[60] E. Sidransky,et al. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. , 1997, American journal of medical genetics.
[61] S. Panny,et al. Hydrops fetalis associated with Gaucher disease. , 1984, Pathology, research and practice.
[62] Yutaka Uno,et al. HISTOCHEMICAL STUDIES IN WOLMAN'S DISEASE – REPORT OF AN AUTOPSY CASE ACCOMPANIED WITH A LARGE AMOUNT OF MILKY ASCITES – , 1973, Acta pathologica japonica.
[63] Peter Congdon,et al. Multiple sulphatase deficiency presenting at birth , 1986, Clinical genetics.
[64] N. Amano,et al. β‐Galactosidase–neuraminidase deficiency (galactosialidosis): Clinical, pathological, and enzymatic studies in a postmortem case , 1983, Annals of neurology.
[65] F. Gottrand,et al. [Fatal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1/NPC2]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[66] G. Hutchins,et al. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. , 1978, American heart journal.
[67] H. Kayserili,et al. Short Femurs Detected at 25 and 31 Weeks of Gestation Diagnosed as Leroy I-Cell Disease in the Postnatal Period: A Report of Two Cases , 2007, Fetal Diagnosis and Therapy.
[68] H. Osawa,et al. Identification of Gaucher cells in the chorionic villi associated with recurrent hydrops fetalis. , 1998, Placenta.
[69] W. Sly,et al. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. , 1996, American Journal of Human Genetics.
[70] M. Tasso,et al. GM1-Gangliosidosis presenting as nonimmune hydrops fetalis: a case report , 1996, Journal of perinatal medicine.
[71] I. Krägeloh-Mann,et al. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. , 2006, Experimental hematology.
[72] F. Gottrand,et al. Neonatal cholestasis and infantile Gaucher disease: a case report , 2002, Acta paediatrica.
[73] J. Groener,et al. New mutations in two Dutch patients with early infantile galactosialidosis. , 2003, Molecular genetics and metabolism.
[74] V. Wiley,et al. Application of tandem mass spectrometry to biochemical genetics and newborn screening. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[75] D. Bonneau,et al. Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects , 2000, Prenatal diagnosis.
[76] R. Choong,et al. Collodion babies with Gaucher's disease. , 1988, Archives of disease in childhood.
[77] G. Donnell,et al. Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis. , 1985, American journal of diseases of children.
[78] W. Bradford,et al. Infantile sialic acid storage disease: a rare cause of cytoplasmic vacuolation in pediatric patients. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.
[79] S. Gerson,et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.
[80] Y. Nevo,et al. Early peripheral nervous system manifestations of infantile Krabbe disease. , 2003, Pediatric neurology.
[81] M. Poe,et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. , 2005, The New England journal of medicine.
[82] P. Morel,et al. Tache mongolique étendue révélant une maladie de Hurler. , 1999 .
[83] P. Meikle,et al. Diagnosis of lysosomal storage disorders: current techniques and future directions , 2004, Expert review of molecular diagnostics.
[84] D. Cole,et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism , 2005, European Journal of Pediatrics.
[85] K. Lukong,et al. Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation , 2001, European Journal of Pediatrics.
[86] L. Becker,et al. Vascular pathology in galactosialidosis. , 1999, Ultrastructural pathology.
[87] P. McCourt,et al. Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. , 1991, American journal of human genetics.
[88] M. Bashyam,et al. Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family , 2006, Journal of Human Genetics.
[89] A. Poulos,et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses , 1989, European Journal of Pediatrics.
[90] P. Josset,et al. Perinatal‐lethal Gaucher disease , 2003, American journal of medical genetics. Part A.
[91] M. Owada,et al. [Lysosomal disorders]. , 2002, Ryoikibetsu shokogun shirizu.
[92] D. Chitayat,et al. Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up. , 1999, American journal of medical genetics.
[93] A. Redington,et al. Fragile X mental retardation. , 1990, Archives of disease in childhood.
[94] C. Peters,et al. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines , 2003, Bone Marrow Transplantation.
[95] W. Schlote,et al. Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria , 1986, Human Genetics.
[96] S. Sherlock,et al. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.
[97] R. Dwek,et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.
[98] J. Nelson,et al. Foamy changes of placental cells in probable beta glucuronidase deficiency associated with hydrops fetalis. , 1993, Journal of clinical pathology.
[99] D. Chace,et al. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. , 2002, Annual review of genomics and human genetics.
[100] V. Yu,et al. Nonimmunologic Hydrops Fetalis: A Review of 61 Cases , 1982, Obstetrics and gynecology.
[101] J. Hoo,et al. Difficulty in Recognizing Multiple Sulfatase Deficiency in an Infant , 2006, Pediatrics.
[102] M. Groll,et al. Hydrops fetalis due to infantile Gaucher's disease. , 1973, The Journal of pediatrics.
[103] R. Schreiber,et al. Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. , 2001, Journal of pediatric gastroenterology and nutrition.
[104] I. Akaboshi,et al. The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: Possible linkage between HLA and the neuraminidase deficiency gene , 1985, Human Genetics.
[105] L. Gort,et al. A new infantile case of α-N-acetylgalactosaminidase deficiency. Cardiomyopathy as a presenting symptom , 2007, Journal of Inherited Metabolic Disease.
[106] M. Beck,et al. Neuraminidase deficiency presenting as non-immune hydrops fetalis , 1984, European Journal of Pediatrics.
[107] Atul Mehta,et al. Lysosomal Storage Disorders , 2005 .
[108] R. Wevers,et al. HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients. , 1994, Clinical chemistry.
[109] H. Tamary,et al. GM1 gangliosidosis presenting as neonatal ascites. , 1982, The Journal of pediatrics.
[110] R. Froissart,et al. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). , 1996, Clinica chimica acta; international journal of clinical chemistry.
[111] A. Sewell,et al. Fetal presentation of morquio disease type A , 1992, Prenatal diagnosis.
[112] E. Kattner,et al. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease , 1997, European Journal of Pediatrics.
[113] R. Saul,et al. Prenatal mucolipidosis type II (I‐cell disease) can present as Pacman dysplasia , 2005, American journal of medical genetics. Part A.
[114] R. Bouvier,et al. Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero , 2005, Journal of Medical Genetics.
[115] K. Murphy,et al. Recurrent Fetal Hydrops due to Mucopolysaccharidoses Type VII , 2006, Fetal Diagnosis and Therapy.
[116] P. Meikle,et al. Lysosomal storage disorders: emerging therapeutic options require early diagnosis , 2003, European Journal of Pediatrics.
[117] Barry Byrne,et al. Diagnostic challenges for Pompe disease: An under-recognized cause of floppy baby syndrome , 2006, Genetics in Medicine.
[118] W. Sly,et al. Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. , 1982, The Journal of pediatrics.
[119] Anthony H. Futerman,et al. The cell biology of lysosomal storage disorders , 2004, Nature Reviews Molecular Cell Biology.
[120] G. Coppa,et al. Neonatal mucolipidosis II (I-cell disease): clinical, radiological and biochemical studies in a case. , 1980, Helvetica paediatrica acta.
[121] E. Sidransky,et al. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease. , 1995, American journal of medical genetics.
[122] R. Van Tiggelen,et al. Gaucher disease , 2019, Haematology.
[123] Yoshiyuki Suzuki,et al. Fibroblast screening for chaperone therapy in beta-galactosidosis. , 2006, Brain & development.
[124] I. Liebaers,et al. Unusual early manifestation of multiple sulfatase deficiency. , 1981, Annales de radiologie.
[125] J. Metzl,et al. An Interesting Case of Infant Sudden Death: Severe Hypertrophic Cardiomyopathy in Pompe's Disease , 1999, Pacing and clinical electrophysiology : PACE.
[126] J. Hoeg,et al. Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. , 1984, American journal of human genetics.
[127] Seng H. Cheng,et al. Cell and gene-based therapies for the lysosomal storage diseases. , 2006, Current gene therapy.
[128] J. Ibrahim,et al. Transient Neonatal Hyperparathyroidism: A Presenting Feature of Mucolipidosis Type II , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[129] F. Ovali,et al. Congenital sialidosis. , 1998, The Turkish journal of pediatrics.
[130] P. Meikle,et al. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. , 2001, Clinical chemistry.
[131] E. Bayever,et al. The status of hematopoietic stem cell transplantation in lysosomal storage disease. , 2003, Pediatric neurology.
[132] J. Roth,et al. Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. , 2006, American journal of physiology. Cell physiology.
[133] A. Ballabio,et al. Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[134] S. Brooks,et al. Neonatal Gaucher Disease Presenting as Persistent Thrombocytopenia , 2005, Journal of Perinatology.
[135] S. Withers,et al. High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones. , 2007, Chemistry & biology.
[136] Yoshiyuki Suzuki,et al. Fibroblast screening for chaperone therapy in β-galactosidosis , 2006, Brain and Development.
[137] J. Callahan,et al. Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model? , 1994, Biochemical medicine and metabolic biology.
[138] Y. Eto,et al. Pathological and biochemical studies of fetal Krabbe disease , 1994, Brain and Development.
[139] G. Mieli-Vergani,et al. Fetal ascites: an unusual presentation of Niemann-Pick disease type C. , 1989, Archives of disease in childhood.
[140] A. Beaudet,et al. Genetics and biochemistry of variant human phenotypes , 1989 .
[141] A. Ballabio,et al. Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[142] J. Boelens. Trends in haematopoietic cell transplantation for inborn errors of metabolism , 2006, Journal of Inherited Metabolic Disease.
[143] P. Frediani,et al. Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment , 1989, Pediatric Radiology.
[144] V. Kimonis,et al. Krabbe Disease: Severe Neonatal Presentation With a Family History of Multiple Sclerosis , 2005, Journal of child neurology.
[145] M. Poe,et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.
[146] J. M. Aerts,et al. Manifestations of Fabry disease in placental tissue , 2006, Journal of Inherited Metabolic Disease.
[147] C. D. de Die-Smulders,et al. Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites , 1999, Journal of Inherited Metabolic Disease.
[148] M. Beck. New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy , 2007, Human Genetics.
[149] R. Bouvier,et al. [Diagnosis of lysosomal storage diseases with fetal presentation]. , 1997, Annales de pathologie.
[150] David M. Rapoport,et al. Pompe disease diagnosis and management guideline , 2006, Genetics in Medicine.
[151] P. Bauer,et al. Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. , 2003, Neuropediatrics.
[152] H. Hoyme,et al. Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. , 1981, Journal of medical genetics.
[153] E. Sidransky,et al. The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. , 1996, Journal of medical genetics.
[154] M. Adachi,et al. Fine structure of central nervous system in early infantile Gaucher's disease. , 1967, Archives of pathology.
[155] N. Conradi,et al. Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension. , 1993, Pediatric neurology.
[156] R. Schiffmann,et al. Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease , 2006, Clinical genetics.
[157] J. Wagner,et al. Hematopoietic cell therapy for metabolic disease. , 2007, The Journal of pediatrics.
[158] C. Riely,et al. Niemann-Pick variant lipidosis presenting as "neonatal hepatitis". , 1986, Journal of pediatric gastroenterology and nutrition.
[159] G. Donnell,et al. β-Glucuronidase Deficiency: A Heterogeneous Mucopolysaccharidosis , 1985 .
[160] F. Graham,et al. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus‐mediated expression , 2004, Human mutation.
[161] K. Nicolaides,et al. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. , 1985, American journal of obstetrics and gynecology.
[162] D. Sherer,et al. Gaucher Disease in the Neonate: A Distinct Gaucher Phenotype Is Analogous to a Mouse Model Created by Targeted Disruption of the Glucocerebrosidase Gene , 1992, Pediatric Research.
[163] A. Beaudet,et al. Variation in the phenotypic expression of beta-glucuronidase deficiency. , 1975, The Journal of pediatrics.
[164] E. Ginns,et al. Epidermal Abnormalities May Distinguish Type 2 from Type 1 and Type 3 of Gaucher Disease , 1996, Pediatric Research.
[165] J. Alroy,et al. Infantile sialic acid storage disease associated with renal disease. , 1988, Pediatric neurology.